No black box warning on record for Disopyramide Phosphate

As of the latest FDA labeling reviewed, Disopyramide Phosphate (DISOPYRAMIDE PHOSPHATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Disopyramide Phosphate medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Mortality In the National Heart, Lung and Blood Institute’s Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multi-center, randomized, double-blind study in patients with asymptomatic non-life-threatening ventricular arrhythmias who had had a myocardial infarction more than 6 days but less than 2 years previously, an excessive mortality or non-fatal cardiac arrest rate (7.7%) was

No black box warning on record for Disopyramide Phosphate

Other warnings & precautions

WARNINGS Mortality In the National Heart, Lung and Blood Institute’s Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multi-center, randomized, double-blind study in patients with asymptomatic non-life-threatening ventricular arrhythmias who had had a myocardial infarction more than 6 days but less than 2 years previously, an excessive mortality or non-fatal cardiac arrest rate (7.7%) was

Disopyramide Phosphate Black Box Warning

No black box warning on record for Disopyramide Phosphate

Other warnings & precautions

Disopyramide Phosphate Black Box Warning

No black box warning on record for Disopyramide Phosphate

Other warnings & precautions